Tired of Cancer B.V. Launches Cancer-Related Fatigue Research featuring Mobile App Untire

Friday, February 15, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Tired of Cancer B.V. has launched its U.S. research study into the effectiveness of the Untire mobile app and reducing Cancer-Related Fatigue (CRF), the most common side-effect of cancer.

UTRECHT, Netherlands, Feb. 15, 2019 /PRNewswire-PRWeb/ -- Tired of Cancer B.V. has launched its research study into the

effectiveness of the Untire mobile app and reducing Cancer-Related Fatigue (CRF), the most common side-effect of cancer. Almost 40% of all cancer patients and survivors suffer from enduring and severe fatigue. Untire is developed to reduce the fatigue and to improve quality of life. It offers a mobile self-management program. Through the Untire app, patients will obtain insight into their own thoughts, emotions and behavior, related to their fatigue. This allows them to identify factors that cause and maintain their unique vicious circle of cancer-related fatigue allowing them to adjust their behaviors leading to improvement of energy levels and quality of life. "CRF is a very serious side-effect, however, both patients and doctors tend not to talk about it. One of the reasons is that there was no concrete solution for CRF available. Now there is," said Tired of Cancer co-founder, Ms. Door Vonk, MA.

The research will focus on two areas:

1) Research led by Cobi J. Heijnen Ph.D. and team will evaluate the Untire app and its impact on fatigue and quality of life of cancer patients and survivors at The University of Texas MD Anderson Cancer Center.

2) Implement a provider support guide to stimulate dialog between CRF patients and healthcare providers in the context of blended care.

According to Tired of Cancer CEO and Co-Founder, Dr. Bram Kuiper, "Our aim is to help healthcare providers address CRF, support them with a concrete, digital solution and give cancer patients and survivors the fatigue specific resources they need."

The Untire self-management program provides a comprehensive, easy-to-use daily program comprised of the following features:

  • Education to better understand fatigue and deal with relevant issues such as anxiety and sleeping problems
  • Tips and reminders to improve lifestyle
  • Exercises for body and mind to reduce stress and increase energy levels
  • Online community for support and communication with CRF peers
  • Weekly reporting to keep track of energy levels and progress

"We are proud that we can provide this new resource, which is so important for cancer patients and healthcare providers," says Dr. Kuiper. "There is now great interest, among patients, patient advocacy groups, hospitals, oncologists and nurses to use the app in blended care; the combination of regular medical treatments and online support."

Recruitment of patients and survivors for the study is now active. The study is expected to culminate in 2021. More study record details for NCT03809130 can be found at https://clinicaltrials.gov/ct2/show/NCT03809130?term=Untire&cntry=US&state=US%3ATX&rank=1

About Tired of Cancer B.V.: In 2013, Dr. Bram Kuiper, together with Door Vonk, MA established Tired of Cancer after working for 30 years in the field of psycho-oncology. Tired of Cancer is committed to helping as many cancer patients and survivors as possible all over the world to improve energy levels and regain a better quality of life. At the heart of Tired of Cancer are more than two decades of psychological interventions and academic research. . Tired of Cancer is a content driven social enterprise committed to investing future revenues into the development of new cancer fatigue solutions. For more information about Tired of Cancer and the Untire app visit http://www.tiredofcancerapp.com and http://www.untire.me

Contact information Lucasbolwerk 6 3512 EG Utrecht, Netherlands Email: info@tiredofcancerapp.com

Media Contact information Email: press@untire.me Press Kit: https://untire.me/press/


SOURCE Tired of Cancer B.V.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store